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The utilization of colonoscopy in Germany
Abstract
Colorectal cancer is one of the three most common cancers in German adults. There are several legally based 
examinations for the early detection of colorectal cancer. People aged 50 to 54 years can have a faecal blood test 
annually. From the age of 55, this test is offered every two years as part of cancer screening, or alternatively a 
preventive colonoscopy, which can be repeated after ten years if the findings are inconspicuous. However, 
colonoscopies are also carried out to clarify complaints or other diseases (curative colonoscopy). In the GEDA 
2014/2015-EHIS study, the respondents provided the date of their last colonoscopy. No data was collected on the 
reason why this colonoscopy was performed. 57% of women and 61% of men aged 55 years or older reported that 
they had a colonoscopy within the last 10 years. New legal regulations envisage the expansion of colorectal cancer 
screening and its development into an organised, quality-assured early detection programme.
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Introduction
Colorectal cancer is one of the three most common types 
of cancer among women and men in Germany; approxi- 
mately one in eight new case of cancer affects the intes-
tine. The risk of developing the disease increases steadi- 
ly with age, and the majority of patients diagnosed with 
this condition are over 70 years old [1]. In 2015, every 
ninth death from cancer was attributable to cancer of 
the intestine. This makes colorectal cancer the third most 
common cause of death from cancer among men and 
women in Germany [2].
There are several legally based examinations for the 
early detection of colorectal cancer. According to the 
cancer screening guidelines, people aged 50 to 54 years 
can have a faecal blood test annually. Faecal blood can 
be an indication of intestinal polyps or even cancer and 
a positive result needs to be clarified by a colonoscopy. 
People aged 55 or over with a negative result can repeat 
the test as part of the cancer screening framework every 
two years [3]. As an alternative, people aged 55 or above 
are offered an early detection colonoscopy (preventive 
colonoscopy), which can be repeated after ten years if 
the test returns a negative result.
The general aim of cancer screening is to detect can-
cer and its precursors as early as possible so as to 
improve patients’ chances of recovery and their quality 
of life and therefore reduce cancer-specific disease fre-
quency and mortality. Colonoscopy involves examining 
the entire length of the colon for proliferation of the 
intestinal mucosa, known as intestinal polyps, as well 
as the presence of potentially cancerous tissue. The 
intestinal polyps from which colorectal cancer can 
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develop can usually be removed during the examination. 
In addition to the early detection of malignant tumours, 
colonoscopies can even help prevent colorectal cancer 
from developing at all. However, a colonoscopy is also 
performed to clarify symptoms and findings, such as 
visible blood in the stool, changes in bowel movements 
over several weeks or abdominal pain and cramps, 
which indicate an already existing (other) bowel disease. 
Colonoscopy is an elaborate procedure that is often 
viewed as unpleasant. However, it rarely results in com-
plications that require treatment [4]. If complications 
do occur, they usually involve bleeding caused by the 
removal of intestinal polyps and only require outpatient 
treatment. 
Since 2003, there has been a decline in the number 
new cases of colorectal cancer in Germany. The age-stand-
ardised incidence rate, which takes into account the 
aging population, has fallen by about 18% among women 
and about 16% among men during this period [5]. This 
is seen as a positive result of colorectal cancer screen-
ing programme which was introduced in 2002. Never-
theless, 28,360 women and 34,050 were newly diagnosed 
with colorectal cancer in 2013 and 12,085 women and 
13,608 men died from it [6].
Indicator
In the GEDA 2014/2015-EHIS study collected data on 
the utilization of the last colonoscopy using a self-ad-
ministered questionnaire which the respondents com-
pleted on paper or online. It included the question: 
‘When was the last time you had colonoscopy?’ The fol-
lowing answers were accepted: ‘Within the past 
12 months’, ‘1 to less than 5 years ago’, ‘5 to less than 
10 years ago’, ‘10 years ago or more’ and ‘Never’. 
This Fact sheet evaluates the utilization of the last 
colonoscopy undertaken within the last 10 years for 
women and men aged 55 and over. It is thus based on 
the recommendations for the cancer screening guide-
lines [3]. The results are stratified according to gender, 
age and level of education.
The analyses are based on data from 9,489 people 
(4,878 women; 4,611 men) aged 55 years or above at the 
time the survey was undertaken with valid data on the 
utilization of their last colonoscopy. All calculations were 
carried out using a weighting factor that corrects for 
deviations within the sample for the German popula-
tion (as of 31 December 2014) with regard to gender, 
age, district type and level of education. The district type 
reflects the degree of urbanisation and accounts for the 
regional distribution in Germany. The International 
Standard Classification of Education (ISCED) was used 
to classify the educational and occupational qualifica-
tions [7]. A detailed description of GEDA 2014/2015-
EHIS can be found in Lange et al. 2017 [8] as well as in 
the article German Health Update: New data for Ger-
many and Europe in issue 1/2017 of the Journal of 
Health Monitoring.
Results and discussion
According to GEDA 2014/2015-EHIS data, 56.6% of 
women and 60.8% of men in Germany aged 55 years or 
over reported that they had undergone a colonoscopy 
within the last 10 years (Table 1). Furthermore, less than 
half of women and men aged between 55 and 59 report-
GEDA 2014/2015-EHIS
Data holder: Robert Koch Institute
Aims: To provide reliable informa tion 
about the population’s health status, 
health-related behaviour and health care  
in Germany, with the possibility of a  
European comparison 
Method: Questionnaires completed on 
paper or online
Population: People aged 18 years and above 
with permanent residency in Germany
Sampling: Registry office sample; randomly 
selected individuals from 301 communities 
in Germany were invited to participate
Participants: 24,016 people (13,144 women; 
10,872 men)
Response rate: 26.9%
Study period: November 2014 - July 2015
Data protection: This study was undertaken 
in strict accordance with the data protection 
regulations set out in the German Federal 
Data Protection Act and was approved by 
the German Federal Commissioner for Data 
Protection and Freedom of Information.  
Participation in the study was voluntary. 
The participants were fully informed about 
the study’s aims and content, and about 
data protection. All participants provided 
written informed consent.
 
More information in German is available at 
www.geda-studie.de
Journal of Health Monitoring
Journal of Health Monitoring 2017 2(4)
FACT SHEETThe utilization of colonoscopy in Germany
78
that 58.6% of women and 56.7% of men aged between 
55 and 79 years reported having undergone a colonos-
copy during the past 10 years [9]. The study also found 
no differences with regard to the utilization of colonos-
copies going by socioeconomic status. As in GEDA 
2014/2015-EHIS the reason for the colonoscopy were 
not asked.
Therefore, it is not possible to use this data to make 
valid conclusions about whether a colonoscopy was 
undertaken as part of cancer screening or due to the 
presence of relevant symptoms. In addition, it is unclear 
whether the examinations were carried out as part of 
outpatient treatment or during hospital stays. As such, 
ed that they had undergone a colonoscopy in the last 10 
years. There are no differences between woman and men 
in terms of educational levels. A higher proportion of 
men aged 70 years or above has undergone a colonos-
copy within the last 10 years than women of the same 
age.
The proportion of people who reported having under-
gone a colonoscopy does not differ significantly between 
the federal states (data not shown).
A comparison of these results with those gained from 
the German Health Interview and Examination Survey 
for Adults (DEGS1, 2008-2011) shows that utilization 
has not changed significantly over time. DEGS1 found 
Table 1 
The utilization of the last colonoscopy within 
the last 10 years among people aged 55 years 
or over by sex, age and educational level 
(n=4,878 women; n=4,611 men) 
Source: GEDA 2014/2015-EHIS
Women % (95% CI)
Women (total) 56.5 (54.7-58.2)
55-59 Years 42.8 (39.5-46.2)
Low education 43.6 (35.1-52.4)
Medium education  41.9 (37.4-46.5)
High education 45.5 (39.3-51.5)
60-64 Years 57.4 (53.9-60.9)
Low education 54.6 (46.6-62.3)
Medium education  56.9 (52.0-61.6)
High education 62.7 (56.2-68.9)
65-69 Years 64.6 (60.6-68.4)
Low education 56.2 (48.3-63.8)
Medium education  68.1 (62.6-73.1)
High education 65.3 (57.4-72.5)
≥70 Years 59.1 (56.6-61.6)
Low education 55.7 (51.7-59.7)
Medium education  61.8 (58.3-65.2)
High education 64.0 (57.1-70.3)
Total (women and men) 58.5 (57.3-59.7)
CI=confidence interval
Men % (95% CI)
Men (total) 60.8 (59.1-62.5)
55-59 Years 48.5 (44.7-52.2)
Low education 52.5 (41.6-63.2)
Medium education  48.2 (42.6-53.8)
High education 46.8 (41.5-52.2)
60-64 Years 58.5 (54.7-62.2)
Low education 60.6 (48.7-71.3)
Medium education  55.3 (49.3-61.1)
High education 63.3 (57.8-68.8)
65-69 Years 63.1 (59.0-66.9)
Low education 61.3 (50.5-71.0)
Medium education  60.7 (54.5-66.5)
High education 67.8 (62.5-72.6)
≥70 Years 67.5 (65.0-70.0)
Low education 69.1 (64.0-73.7)
Medium education  66.3 (62.5-69.9)
High education 68.7 (64.5-72.6)
Total (women and men) 58.5 (57.3-59.7)
57% of women and 61% of 
men aged 55 years or older 
reported that they had a  
colonoscopy within the last 
10 years.
i
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low-fiber diets and eat a lot of red meat or processed 
products are more likely to fall ill [4, 11]. However, the 
extent to which the risk of colorectal cancer can be 
reduced by changing the lifestyle is not certain [4]. 
In Germany, the 2008 implementation of the National 
Cancer Plan [12] led to a reorganisation of cancer screen-
ing. Moreover, the 2013 Cancer Screening and Registers 
Act established a legal basis with which to conceptually 
develop the early detection of colorectal cancer into an 
organised, quality-assured screening programme [13]. In 
particular, the eligibility criteria, the invitation procedure 
and the information to be provided to patients are to be 
revised. The invitation to screening and the information 
provided to patients are intended to assist people who 
are eligible for screening to decide whether they want to 
take part. The explicit aim is to provide more compre-
hensive information on the early detection of colorectal 
cancer and to promote the formation of an informed 
decision on participation [14]. It has already been real-
ised that the fecal occult blood test has been carried out 
since January 2017 with a quantitative immunological 
test (i-FOBT) [3]. The systematic collection, monitoring 
and improvement of the quality of the structure, process 
and outcome quality of colorectal cancer screening, 
which is aimed for in the screening program, allows a 
more precise estimation of the effect of early detection 
colonoscopy on colorectal cancer incidence and mortal-
ity to be expected.
other data sources are needed in order to estimate the 
utilization of early detection colonoscopy in Germany. 
Since the introduction of early detection colonoscopy in 
Germany in 2002, the Central Research Institute for 
Ambulatory Health Care in Germany (Zi) has been com-
missioned with undertaking scientific accompanying 
research. The institute provides estimates of utilization 
and assesses the quality of the examinations as well as 
the findings they produce. The data used by the institute 
comes from the routine documentation provided by the 
doctors who undertake the detection colonoscopies, 
which is sent to the Zi by the Association of Statutory 
Health Insurance Physicians (KV). These data demon-
strate a cumulative rate of utilization of early detection 
colonoscopy among men and women aged 55 years or 
above of 20.8% for 2003 to 2014 [10]. This rate is signif-
icantly lower than the rate identified by GEDA 2014/2015-
EHIS as the GEDA study only includes data on early 
detection colonoscopies carried out on an outpatient 
basis.
The data available from GEDA 2014/2015-EHIS pro-
vide a depiction of the utilization of colonoscopy in Ger-
many. Both symptom-based (curative) colonoscopy and 
early-detection colonoscopy involve the same procedure 
– the removal of polyps (adenomas) in order to reduce 
the risk of colorectal cancer. From this it can be deduced 
that the relatively high prevalence of colonoscopy as a 
follow-up examination has also contributed to a reduced 
incidence of colorectal cancer in Germany, even though 
the effect cannot yet be quantified exactly. 
The main risk factors for colorectal cancer are smok-
ing and obesity but also those who exercise little, eat 
Colonoscopies are less 
frequently reported by 
women and men under  
the age of 60 years than  
by older age groups.
In the 70-year-old and elderly 
age group, significantly more 
men than women report a 
colonoscopy.
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